K Number
K223759
Device Name
Arthrex SynergyID Endoscopic Imaging System
Manufacturer
Date Cleared
2023-02-24

(71 days)

Product Code
Regulation Number
876.1500
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Arthrex SynergyID Endoscopic Imaging System is intended to be used as an endoscopic video camera to provide visible light imaging in a variety of endoscopic diagnostic and surgical procedures, including but not limited to: orthopedic, spine, laparoscopic, urologic, sinuscopic, plastic surgical procedures within the thoracic cavity. The device is also intended to be used as an accessory for microscopic surgery. The Arthrex SynergyID Endoscopic Imaging System is indicated for use to provide real time endoscopic visible and nearinfrared fluorescence imaging. Upon intravenous administration and use of ICG consistent with its approved label, the system enables surgeons to perform minimally invasive surgery using standard endoscope visible light as well as visualization of vessels, blood flow and related tissue perfusion, and at least one of the major extra-hepatic bile ducts (cystic duct, common bile duct or common hepatic duct), using near-infrared imaging. Fluorescence imaging of biliary ducts with the Arthrex SynergyID Endoscopic Imaging System is intended for use with standard of care white light, and when indicated, intraoperative cholangiography. The device is not intended for standalone use for billary duct visualization. Upon interstitial administration and use of ICG consistent with its approved label, the Arthrex SynergyID Endoscopic Imaging System is used to perform intraoperative fluorescence imaging and visualization of the lymphatic system, including lymphatic vessels and lymph nodes.
Device Description
The Arthrex Synergy® Endoscopic Imaging System includes a non-sterile camera control unit (CCU) console, camera heads, a laser light source, and laparoscopes. The system integrates ultra-high-definition camera technology, LED lighting, and an image management system into a single console with a tablet interface. The system provides real-time visible and near-infrared light illumination and imaging. The Arthrex Synergy® Endoscopic Imaging System CCU interacts with the laser light source to be able to provide near-infrared (NIR) imaging to visualize the presence of Indocyanine Green (ICG). The ICG fluoresces when illuminated through a laparoscope with NIR excitation light from the laser light source and the fluorescence response is then imaged with the camera, processed and displayed on a monitor.
More Information

Not Found

No
The summary describes standard endoscopic imaging technology with visible and near-infrared light, image processing for display, and software validation. There is no mention of AI, ML, or any features indicative of learning or adaptive algorithms.

No
The device is described as an endoscopic video camera and imaging system used for diagnosis and surgical procedures, not for direct therapeutic treatment.

Yes

The "Intended Use / Indications for Use" section explicitly states that the device provides "visible light imaging in a variety of endoscopic diagnostic and surgical procedures." It also mentions "visualization of vessels, blood flow and related tissue perfusion" and "fluorescence imaging of biliary ducts," which are diagnostic activities.

No

The device description explicitly lists hardware components such as a camera control unit (CCU) console, camera heads, a laser light source, and laparoscopes. While it includes software, it is not solely software.

Based on the provided information, the Arthrex SynergyID Endoscopic Imaging System is not an In Vitro Diagnostic (IVD).

Here's why:

  • Intended Use: The intended use clearly states the device is for endoscopic imaging during surgical and diagnostic procedures. It visualizes anatomical structures in vivo (within the living body) using visible and near-infrared light.
  • Device Description: The description details a system for capturing and displaying images from within the body. It involves a camera, light source, and image processing, all focused on visualizing internal anatomy.
  • Lack of In Vitro Activities: There is no mention of the device being used to examine specimens outside of the body, such as blood, tissue samples, or other bodily fluids. IVDs are specifically designed for testing these types of samples in a laboratory setting.

The device is an in vivo imaging system used during surgical and diagnostic procedures, not an IVD.

N/A

Intended Use / Indications for Use

The Arthrex SynergyID Endoscopic Imaging System is intended to be used as an endoscopic video camera to provide visible light imaging in a variety of endoscopic diagnostic and surgical procedures, including but not limited to: orthopedic, spine, laparoscopic, urologic, sinuscopic, plastic surgical procedures within the thoracic cavity. The device is also intended to be used as an accessory for microscopic surgery.

The Arthrex SynergyID Endoscopic Imaging System is indicated for use to provide real time endoscopic visible and nearinfrared fluorescence imaging. Upon intravenous administration and use of ICG consistent with its approved label, the system enables surgeons to perform minimally invasive surgery using standard endoscope visible light as well as visualization of vessels, blood flow and related tissue perfusion, and at least one of the major extra-hepatic bile ducts (cystic duct, common bile duct or common hepatic duct), using near-infrared imaging. Fluorescence imaging of biliary ducts with the Arthrex SynergyID Endoscopic Imaging System is intended for use with standard of care white light, and when indicated, intraoperative cholangiography. The device is not intended for standalone use for billary duct visualization.

Upon interstitial administration and use of ICG consistent with its approved label, the Arthrex SynergyID Endoscopic Imaging System is used to perform intraoperative fluorescence imaging and visualization of the lymphatic system, including lymphatic vessels and lymph nodes.

Product codes

GCJ, IZI

Device Description

The Arthrex Synergy® Endoscopic Imaging System includes a non-sterile camera control unit (CCU) console, camera heads, a laser light source, and laparoscopes. The system integrates ultra-high-definition camera technology, LED lighting, and an image management system into a single console with a tablet interface. The system provides real-time visible and near-infrared light illumination and imaging.

The Arthrex Synergy® Endoscopic Imaging System CCU interacts with the laser light source to be able to provide near-infrared (NIR) imaging to visualize the presence of Indocyanine Green (ICG). The ICG fluoresces when illuminated through a laparoscope with NIR excitation light from the laser light source and the fluorescence response is then imaged with the camera, processed and displayed on a monitor.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Visible light imaging, near-infrared fluorescence imaging

Anatomical Site

vessels, blood flow and related tissue perfusion, and at least one of the major extra-hepatic bile ducts (cystic duct, common bile duct or common hepatic duct), lymphatic system, including lymphatic vessels and lymph nodes.

Indicated Patient Age Range

Not Found

Intended User / Care Setting

surgeons

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Performance Data:
Conformance to the following standards was demonstrated:
Biocompatibility:
ISO 10993-5:2009
ISO 10993-10:2010

Electrical Safety and EMC:
AAMI/ANSI ES60601-1:2005(R) 2012 and A1:2012
IEC 60601-1-2:2014

Software Validation and Verification Testing:
Software verification and validation testing were conducted and documentation was provided as recommended by FDA's Guidance for Industry and FDA Staff, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices." The software for this device was considered as a "moderate" level of concern. Activities included software validation/verification, regression testing, unit testing, code reviews and checks and integration testing.

Bench Testing:
Verification activities including engineering evaluation and functional analysis were conducted to demonstrate the accessory spine endoscopes are compatible with the Arthrex Synergy/D Endoscopic Imaging System. All verification activities conducted were successful and confirmed the accessory spine endoscopes are compatible with the Arthrex Synergy/D Endoscopic Imaging System.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K202582, K182606, K201526, K201134

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 876.1500 Endoscope and accessories.

(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.

0

Image /page/0/Picture/10 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.

February 24, 2023

Arthex Inc. Troy Brooks Regulatory Affairs Team Lead 1370 Creekside Boulevard Naples, Florida 34108-1945

Re: K223759

Trade/Device Name: Arthrex SynergyID Endoscopic Imaging System Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscope And Accessories Regulatory Class: Class II Product Code: GCJ, IZI Dated: February 16, 2023 Received: February 17, 2023

Dear Troy Brooks:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part

1

801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Colin K. Chen -S

Colin Kejing Chen Acting Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K223759

Device Name

Arthrex SynergyID Endoscopic Imaging System

Indications for Use (Describe)

The Arthrex SynergyID Endoscopic Imaging System is intended to be used as an endoscopic video camera to provide visible light imaging in a variety of endoscopic diagnostic and surgical procedures, including but not limited to: orthopedic, spine, laparoscopic, urologic, sinuscopic, plastic surgical procedures within the thoracic cavity. The device is also intended to be used as an accessory for microscopic surgery.

The Arthrex SynergyID Endoscopic Imaging System is indicated for use to provide real time endoscopic visible and nearinfrared fluorescence imaging. Upon intravenous administration and use of ICG consistent with its approved label, the system enables surgeons to perform minimally invasive surgery using standard endoscope visible light as well as visualization of vessels, blood flow and related tissue perfusion, and at least one of the major extra-hepatic bile ducts (cystic duct, common bile duct or common hepatic duct), using near-infrared imaging. Fluorescence imaging of biliary ducts with the Arthrex SynergyID Endoscopic Imaging System is intended for use with standard of care white light, and when indicated, intraoperative cholangiography. The device is not intended for standalone use for billary duct visualization.

Upon interstitial administration and use of ICG consistent with its approved label, the Arthrex SynergyID Endoscopic Imaging System is used to perform intraoperative fluorescence imaging and visualization of the lymphatic system, including lymphatic vessels and lymph nodes.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

Date PreparedJanuary 27, 2023
SubmitterArthrex Inc.
1370 Creekside Boulevard
Naples, FL 34108-1945
Contact PersonTroy Brooks, RAC
Regulatory Affairs Team Lead
1-239-643-5553
Troy.Brooks@Arthrex.com
Name of DeviceArthrex Synergy® Endoscopic Imaging System
Common NameEndoscopic Video Imaging System
Product CodeGCJ, IZI
Classification Name21 CFR 876.1500: Endoscope and accessories
21 CFR 892.1600: Angiographic x-ray systems
Regulatory ClassII
Primary Predicate
DeviceK202582 - Arthrex Synergy® Endoscopic Imaging System, Arthrex Inc.
Additional Predicate
DevicesK182606 - PINPOINT Endoscopic Fluorescence Imaging System, Novadaq Technologies
K201526 - TIPCAM1 Rubina Video Endoscope System, Karl Storz Endoscopy America
K201134 - Arthrex NanoScope System, Arthrex Inc.
Purpose of SubmissionThis Traditional 510(k) premarket notification is submitted to obtain clearance for
expanded indications for use for the existing Arthrex Synergy® Endoscopic Imaging
System cleared under K202582.
Device DescriptionThe Arthrex Synergy® Endoscopic Imaging System includes a non-sterile camera
control unit (CCU) console, camera heads, a laser light source, and laparoscopes.
The system integrates ultra-high-definition camera technology, LED lighting, and
an image management system into a single console with a tablet interface. The
system provides real-time visible and near-infrared light illumination and imaging.
The Arthrex Synergy® Endoscopic Imaging System CCU interacts with the laser light
source to be able to provide near-infrared (NIR) imaging to visualize the presence of
Indocyanine Green (ICG). The ICG fluoresces when illuminated through a laparoscope
with NIR excitation light from the laser light source and the fluorescence response is
then imaged with the camera, processed and displayed on a monitor.
Indications for UseThe Arthrex Synergy® Endoscopic Imaging System is intended to be used as an
endoscopic video camera to provide visible light imaging in a variety of endoscopic
diagnostic and surgical procedures, including but not limited to: orthopedic, spine,
laparoscopic, urologic, sinuscopic, plastic surgical procedures, and procedures within
the thoracic cavity. The device is also intended to be used as an accessory for
microscopic surgery.
The Arthrex Synergy® Endoscopic Imaging System is indicated for use to provide real
time endoscopic visible and near-infrared fluorescence imaging. Upon intravenous
administration and use of ICG consistent with its approved label, the system enables
surgeons to perform minimally invasive surgery using standard endoscope visible
light as well as visualization of vessels, blood flow and related tissue perfusion, and
at least one of the major extra-hepatic bile ducts (cystic duct, common bile duct or
common hepatic duct), using near-infrared imaging. Fluorescence imaging of biliary
ducts with the Arthrex Synergy® Endoscopic Imaging System is intended for use with
standard of care white light, and when indicated, intraoperative cholangiography.
The device is not intended for standalone use for biliary duct visualization.
Upon interstitial administration and use of ICG consistent with its approved label,
the Arthrex Synergy® Endoscopic Imaging System is used to perform intraoperative
fluorescence imaging and visualization of the lymphatic system, including lymphatic
vessels and lymph nodes.

510(k) Summary

4

Technological Comparison

| | Arthrex
SynergyID
Endoscopic
Imaging System | Arthrex
SynergyID
Endoscopic
Imaging System | Novadaq
PINPOINT
Endoscopic
Fluorescence
Imaging System | Karl Storz
TIPCAM1 Rubina
Video Endoscope
System | Arthrex
NanoScope
System | Comparison |
|-------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Device | Subject Device | | K182606
Additional
Predicate | K201526
Additional
Predicate | K201134
Additional
Predicate | |
| Classification | Class II | Class II | Class II | Class II | Class II | Equivalent |
| Product Code | GCJ, IZI | GCJ, IZI | GCJ, IZI | GCJ, FGB, HET | GCJ, HRX | Equivalent |
| 21 CFR | 876.1500
Endoscope and
Accessories | 876.1500
Endoscope and
Accessories | 876.1500
Endoscope and
Accessories | 876.1500
Endoscope and
Accessories | 876.1500
Endoscope and
Accessories | Equivalent |
| Combination
Product | No | No | No | No | No | Equivalent |
| Indications
For Use | The Arthrex
SynergyID
Endoscopic
Imaging System
is intended to
be used as an
endoscopic video
camera to
provide visual
imaging in a
variety of
endoscopic
diagnostic and
surgical
procedures,
including but
not limited to:
orthopedic,
spine,
laparoscopic,
urologic,
sinuscopic,
plastic surgical
procedures,
and procedures
within the
thoracic cavity.
The device is also
intended to be
used as an
accessory for
microscopic
surgery.

The Arthrex
SynergyID
Endoscopic
Imaging System
is indicated for
use to provide
real time
endoscopic
visible and
near-infrared
fluorescence
imaging. Upon
intravenous
administration
and use of ICG
consistent with
its approved | The Arthrex
SynergyID
Endoscopic
Imaging System
is intended to
be used as an
endoscopic video
camera in a
variety of
endoscopic
surgical
procedures,
including but
not limited to:
orthopedic,
laparoscopic,
urologic,
sinuscopic, and
plastic surgical
procedures. The
device is also
intended to be
used as an
accessory for
microscopic
surgery.

The Arthrex
SynergyID
Endoscopic
Imaging System
is indicated for
use to provide
real time
endoscopic
visible and
near-infrared
fluorescence
imaging. Upon
intravenous
administration
and use of ICG
consistent with
its approved
label, the system
enables surgeons
to perform
minimally
invasive surgery
using standard
endoscope | Upon
intravenous
administration
of TRADENAME
(ICG drug
product), the
PINPOINT
Endoscopic
Fluorescence
Imaging System
is used with
TRADENAME to
perform
intraoperative
fluorescence
angiography,
and it is also
indicated for use
in fluorescence
imaging of biliary
ducts, and when
indicated, during
intraoperative
cholangiography.

The PINPOINT
Endoscopic
Fluorescence
Imaging System
is indicated for
use to provide
real time
endoscopic
visible and near-
infrared
fluorescence
imaging. The
PINPOINT
System enables
surgeons to
perform
minimally
invasive surgery
using standard
endoscope
visible light as
well as visual
assessment of
vessels, blood
flow and related
tissue perfusion, | The TIPCAM1
Rubina Video
Endoscope
System is
intended to be
used together
with the camera
control unit
during diagnostic
and/or surgical
procedures
when endoscopic
video assistance
is required. For
use in all
endoscopy and
endoscopic
surgery within
the peritoneal
and thoracic
cavity, including
gynecological
and urological
anatomy. | The Arthrex
NanoScope
System is
intended to be
used as an
endoscopic video
camera in a
variety of
endoscopic
diagnostic and
surgical
procedures,
including but
not limited to:
orthopedic,
spine,
laparoscopic,
urologic,
sinuscopic, and
plastic surgical
procedures. The
device is also
intended to be
used as an
accessory for
microscopic
surgery. | The subject
device includes
the following
additional
indications
for use:

  • fluorescence
    imaging and
    visualization
    of the
    lymphatic
    system,
    including
    lymphatic
    vessels and
    lymph nodes
  • use as an
    endoscopic
    video camera
    (i.e. visual
    imaging) in
    diagnostic
    and surgical
    procedures
    for spine and
    within the
    thoracic cavity |
    | | to perform
    minimally
    invasive surgery
    using standard
    endoscope
    visible light as
    well as
    visualization of
    vessels, blood
    flow and related
    tissue perfusion,
    and at least one
    of the major
    extra-hepatic
    bile ducts (cystic
    duct, common
    bile duct or
    common hepatic
    duct), using
    near-infrared
    imaging.
    Fluorescence
    imaging of biliary
    ducts with the
    Arthrex Synergy®
    Endoscopic
    Imaging System
    is intended for
    use with
    standard of care
    white light, and
    when indicated,
    intraoperative
    cholangiography.
    The device is not
    intended for
    standalone use
    for biliary duct
    visualization.
    Upon interstitial
    administration
    and use of ICG
    consistent with
    its approved
    label, the Arthrex
    SynergyD
    Endoscopic
    Imaging System
    is used to
    perform
    intraoperative
    fluorescence
    imaging and
    visualization of
    the lymphatic
    system, including
    lymphatic vessels
    and lymph
    nodes. | visualization of
    vessels, blood
    flow and related
    tissue perfusion,
    and at least one
    of the major
    extra-hepatic
    bile ducts (cystic
    duct, common
    bile duct or
    common hepatic
    duct), using
    near-infrared
    imaging.
    Fluorescence
    imaging of biliary
    ducts with the
    Arthrex Synergy®
    Endoscopic
    Imaging System
    is intended for
    use with
    standard of care
    white light, and
    when indicated,
    intraoperative
    cholangiography.
    The device is not
    intended for
    standalone use
    for biliary duct
    visualization. | extra-hepatic
    bile ducts (cystic
    duct, common
    bile duct or
    common hepatic
    duct), using
    near-infrared
    imaging.
    Fluorescence
    imaging of biliary
    ducts with the
    PINPOINT
    System is
    intended for use
    with standard of
    care white light,
    and when
    indicated,
    intraoperative
    cholangiography.
    The device is not
    intended for
    standalone use
    for biliary duct
    visualization.
    Upon interstitial
    administration
    of TRADENAME
    (ICG drug
    product), the
    PINPOINT
    System is used
    to perform
    intraoperative
    fluorescence
    imaging and
    visualization of
    the lymphatic
    system, including
    lymphatic vessels
    and lymph
    nodes. | | | |
    | System
    Components | Camera Control
    Unit
    Light Source
    Camera Heads
    Scopes | Camera Control
    Unit
    Light Source
    Camera Heads
    Scopes | Video Processor
    Illuminator (VPI)
    Camera Head
    Scopes | Camera Control
    Unit
    Camera/Scope
    (integrated) | Console
    Camera/Scope
    (integrated) | Equivalent to
    the primary
    predicate
    K202582.
    Similar to
    predicates
    K182606
    and K201526. |
    | Imaging
    Modes | White Light
    NIR Fluorescence | White Light
    NIR Fluorescence | White Light
    NIR Fluorescence | White Light | White Light | Equivalent
    per white light
    indications and
    NIR fluorescence
    indications. |
    | Safety
    Standards | IEC 60601-1
    IEC 60601-1-2
    IEC 60601-2-18
    IEC 60825-1 | IEC 60601-1
    IEC 60601-1-2
    IEC 60601-2-18
    IEC 60825-1 | IEC 60601-1
    IEC 60601-1-2
    IEC 60601-2-18
    IEC 60825-1 | IEC 60601-1
    IEC 60601-1-2
    IEC 60601-2-18 | IEC 60601-1
    IEC 60601-1-2
    IEC 60601-2-18 | Equivalent |
    | Light
    Source | Integrated
    (Visible)
    External (NIR) | Integrated
    (Visible)
    External (NIR) | Integrated | Integrated | Integrated | Equivalent
    to primary
    predicate
    K202582. |
    | Image Sensor | CMOS | CMOS | CMOS | CMOS | CMOS | Equivalent |
    | Image
    Resolution | 3840 x 2160 | 3840 x 2160 | 1920 x 1080 | 3840 x 2160 | 400 x 400 | Equivalent to
    predicates
    K202582 and
    K201526. |
    | Frame
    Rate | 60 FPS | 60 FPS | 60 FPS | 60 FPS | 30 FPS | Equivalent to
    predicates
    K202582,
    K182606 and
    K201526. |
    | Fluorescence
    Imaging
    Excitation
    Source | NIR laser | NIR laser | NIR laser | N/A | N/A | Equivalent |
    | Excitation
    Wavelength | 785nm | 785nm | 805nm | N/A | N/A | Equivalent
    to primary
    predicate
    K202582.
    Similar to
    predicate
    K182606. |
    | Detection
    Bandwidth | 810 to 940 nm | 810 to 940 nm | 825 to 850 nm | N/A | N/A | Equivalent
    to primary
    predicate
    K202582.
    Similar to
    predicate
    K182606.
    See Note 1. |
    | Excitation
    Light Source
    Intensity | 95 W/m² | 95 W/m² | Light source
    is pulsed
    (20 pulses/s,
    2 mJ/pulse) | N/A | N/A | Equivalent
    to primary |
    | Maximum
    Light
    Intensity | 535 lumens | 535 lumens | Light source
    is pulsed
    (20 pulses/s,
    2 mJ/pulse) | N/A | N/A | predicate
    K202582.
    Similar to
    predicate
    K182606. |
    | Maximum
    Output
    Power | 1.37W | 1.37W | Light source is
    pulsed
    (20 pulses/s,
    2 mJ/pulse) | N/A | N/A | See Note 2
    and Note 3. |
    | Depth of
    Observation | 5 – 10mm | 5 – 10mm | Not available | N/A | N/A | Equivalent
    to primary |
    | Lateral
    Resolution | 800 LLLP | 800 LLLP | Not available | N/A | N/A | predicate
    K202582.
    See Note 3. |
    | Contrast
    Agent | Indocyanine
    Green (ICG) | Indocyanine
    Green (ICG) | Indocyanine
    Green (ICG) | N/A | N/A | Equivalent |
    | NIR Scope
    Viewing
    Angle | 0°, 30°, 45° | 0°, 30°, 45° | 0°, 30°, 45° | N/A | N/A | Equivalent |
    | NIR Scope
    Diameter | 5.5mm, 10mm | 5.5mm, 10mm | 5.5mm, 10mm | N/A | N/A | Equivalent |
    | NIR Scope
    Length | 302 – 333mm | 302 – 333mm | 300 – 420mm | N/A | N/A | Equivalent
    to primary
    predicate
    K202582.
    Within range
    of predicate
    K182606. |
    | NIR Scope
    Field of View | 75° | 75° | 70° - 75° | N/A | N/A | Equivalent |
    | (Visible)
    Scope
    Viewing
    Angle | Endoscopes:
    0°, 30°, 45°, 70° | Endoscopes:
    0°, 30°, 45°, 70° | N/A | 0°, 30° | 0° | Endoscopes:
    See Note 4.
    Spine
    Endoscopes:
    See Note 5. |
    | (Visible)
    Scope
    Diameter | Endoscopes:
    1.9mm – 10mm
    Spine
    Endoscopes:
    6.3mm - 10mm | Endoscopes:
    1.9mm – 10mm | N/A | 10mm | 1.9mm | Endoscopes:
    See Note 4.
    Spine
    Endoscopes:
    See Note 5. |
    | (Visible)
    Scope Length | Endoscopes:
    58mm – 459mm
    Spine
    Endoscopes:
    130 - 181mm | Endoscopes:
    58mm – 459mm | N/A | 317 - 320mm | 95mm | Endoscopes:
    See Note 4.
    Spine
    Endoscopes:
    See Note 5. |
    | (Visible)
    Scope Field
    of View | Endoscopes:
    75°– 105°
    Spine
    Endoscopes:
    80° | Endoscopes:
    75°– 105° | N/A | 82° | 120° | Endoscopes:
    See Note 4.
    Spine
    Endoscopes:
    See Note 5. |

5

6

7

Note 1: Detection Bandwidth for the subject device: NIR Sensor Spectral Response: 810mm - 940nm - 940nm. Because the subject device has wider detection bandwidth than the predicate K182606, this difference does not impact safety and effectiveness.

Note 2: The subject device has continuous wave laser whereas the predicate K182606 laser is pulsed. This difference does not impact safety and effectiveness as it is a system design only. Additionally, the existing Synergy® Endoscopic Imaging System (K202582) was deemed to be substantially equivalent to the PINPOINT Endoscopic Fluorescence Imaging System (K150956).

Note 3:

Subiect Device:

Excitation light source intensity: ~95W/m^2 at Light Guide Exit

Maximum light intensity: 535 lumens measured at Endoscope tip, 10mm 0 deg scope

Maximum output power: 1.37W

Dept of observation: 5-10mm

Lateral Resolution: NIR Resolution > 800 LPPH (Lines Per Picture Height) measured using an infrared resolution chart

Predicate K182606:

Dept of observation: Information is not available

Lateral Resolution: Information is not available

Note 4: These endoscopes are existing accessories to the Synergy" Endoscopic Imaging System (K202582). The FDA clearance applicable to these scopes is K941541 and K080560. Safety and effectiveness of the scopes for use in diagnostic and surgical procedures has been previously established as cleared by the FDA under K941541 and K080560.

Note 5: The spine endoscopes are accessories to the Synergy® Endoscopic Imaging System. The FDA clearance applicable to the spine endoscopes is K130778. Safety and effectiveness of the spine endoscopic procedures has been previously established as cleared by the FDA under K130778. As demonstrated within the submission, Arthrex has verified compatibility of the spine endoscopes with the Synergy10 Endoscopic Imaging System.

8

| Performance Data | Conformance to the following standards was demonstrated:
Biocompatibility:
ISO 10993-5:2009
ISO 10993-10:2010 |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | Electrical Safety and EMC:
AAMI/ANSI ES60601-1:2005(R) 2012 and A1:2012
IEC 60601-1-2:2014 |
| | Software Validation and Verification Testing:
Software verification and validation testing were conducted and documentation was
provided as recommended by FDA's Guidance for Industry and FDA Staff, "Guidance
for the Content of Premarket Submissions for Software Contained in Medical
Devices." The software for this device was considered as a "moderate" level of
concern. Activities included software validation/verification, regression testing,
unit testing, code reviews and checks and integration testing. |
| | Bench Testing:
Verification activities including engineering evaluation and functional analysis were
conducted to demonstrate the accessory spine endoscopes are compatible with the
Arthrex Synergy/D Endoscopic Imaging System. All verification activities conducted
were successful and confirmed the accessory spine endoscopes are compatible with
the Arthrex Synergy/D Endoscopic Imaging System. |
| Conclusion | Based on the intended use, technological characteristics, and conducted performance
testing Arthrex has determined that the Synergy/D Endoscopic Imaging System is as
safe and as effective as the predicate devices. Any differences between the proposed
device and predicate devices are considered minor and do not raise different
questions concerning safety and effectiveness. |